Top Shares to Buy Now: Trending Stocks & Expert Picks

The stock market’s loudest conversations aren’t always the most useful. Beneath the familiar headlines about NVIDIA and Tesla lies a noisier picture—UK stocks like Wizz Air surging on volume spikes, small-cap biotech plays posting thousand-percent yearly gains, and mega-cap tech dominating broker flow data. This piece cuts through the clutter by aggregating real-time data from Yahoo Finance, AJ Bell, Hargreaves Lansdown, Barclays, and Morningstar to surface what’s actually moving in the markets right now.

Top Trending US Stocks: MSTR, CRML, AMC, TEVA ·
Most Dealt UK Shares: Barclays, Lloyds ·
Morningstar Best Picks: CPB, SAP, CSGP ·
FTSE Top 40: Index tracked ·
Magnificent 7: Fidelity reference

The following table consolidates the most actionable data points from verified platform sources.

What are the top stocks to buy now?

The answer depends entirely on which market you’re watching—and which lens you’re using. Platforms like Finder UK aggregate data from UK trading apps, trade volume surges, and Reddit mentions to surface what’s genuinely moving, while US-focused tools track yearly performance and algorithmic buy signals. The result is two parallel universes that occasionally overlap.

Trending US stocks

On the US side, the picture is dominated by extreme performers. Regencell Bioscience Holdings (RGC) leads all US best-performing yearly stocks with a staggering +13,300.81% gain as of April 17, 2026, closing at $17.28 per share (TradingView). D-Wave Quantum Inc. (QBTS) follows at +2,890.65%, while Arqit Quantum Inc. (ARQQ) posted +490.52% yearly gains, closing at $42.99 (TradingView). These aren’t household names—they’re the kind of stocks that platform algorithms surface when looking for maximum yearly alpha.

On the more established end, Barchart ranks the top 100 stocks by highest weighted alpha over one year as of April 17, 2026, giving retail investors a more measured view of which companies are consistently outperforming (Barchart). Meanwhile, Investing.com’s trending stocks algorithm uses sentiment analysis to surface names that are gaining attention for reasons beyond pure price movement (Investing.com).

The implication: US trending lists reward volatility chasers, not patient investors. If you’re measuring your portfolio against the S&P 500, these extreme movers will skew your returns in ways that make benchmarking unreliable.

UK popular shares

The UK picture looks notably different. Finder UK’s tool, which scours the internet daily for trending shares from UK apps, volume data, and Reddit, puts Wizz Air (WIZZ) at the top of its best stocks to buy now list with a 505.67% monthly change in trade volume and a latest close at 902p (Finder UK). Vistry Group (VTY) ranks second with a 378.74% volume surge, closing at 421.9p. Taylor Wimpey (TW) takes third place with 289.60% volume change, closing at 98.44p—classified as a penny stock in the UK market (Finder UK).

HSBC (HSBA) ranks fifth with a 192.39% volume change, closing at 1251p, while Aviva (AV) sits at fourth with a 199.07% surge and close at 628.4p (Finder UK). The UK list emphasizes banks and housebuilders—sectors that benefit from domestic economic sentiment in ways the US tech-heavy rankings simply don’t.

Tesla (TSLA) appears in the UK top 25 at #16 with 6.61% volume change and a US stock close of $398.68, while Palantir (PLTR) sits at #19 with 24.49% volume and close at $156.43. Coinbase (COIN) ranks #23 with 39.38% volume, closing at $199.79, and Amazon (AMZN) comes in at #27 with 69.60% volume and close at $213.49 (Finder UK).

The pattern emerging here is clear: UK investors are gravitating toward dividend-paying banks and beaten-down housebuilders, while US retail interest (as measured by UK broker flows) clusters around mega-cap tech. Both strategies have merit, but they’re chasing fundamentally different catalysts.

Which top 10 shares to buy?

When investors search for “top 10 shares to buy,” they’re typically looking for curated lists that distill market noise into actionable picks. The challenge is that every platform builds its list differently—some use volume, others use performance, and some use broker-dealer customer flow data.

Current top 10 lists

Barclays’ most dealt shares between April 10-16, 2026, reveal what actual customers are trading during that window, with Barclays plc and Lloyds appearing as the most frequently traded UK shares (Finder UK). This customer-deal data is inherently backward-looking—it captures what already happened—but it signals which names have enough liquidity and interest to sustain large trades.

Hargreaves Lansdown’s FTSE risers highlight stocks gaining the most ground in percentage terms among UK-listed companies, with Barratt Redrow (BTRW), Compass Group (CPG), and Informa (INF) frequently appearing on recent lists. AJ Bell’s top buys section shows which shares its customers are most actively adding to portfolios, representing a distinct signal from pure price momentum (Finder UK).

Factors for selection

Morningstar takes a different approach, using fundamental analysis to identify what it considers genuine value. Campbell’s (CPB), SAP, and CoStar Group (CSGP) appear as Morningstar best picks, reflecting the platform’s focus on earnings quality, balance sheet strength, and competitive moat rather than pure momentum (Finder UK). These picks carry more analytical weight for long-term investors, though they may underperform momentum-driven lists during hot market periods.

On the algorithmic side, StockInvest.us ranks top buy candidates using proprietary algorithms across 40+ exchanges, aiming to surface stocks with favorable technical and fundamental indicators simultaneously (StockInvest.us). This approach automated what traditional analysts do manually—screening for stocks that score well across multiple metrics—but the methodology varies significantly from platform to platform.

The catch: no single “top 10” list can claim authority over another. Investors must decide which methodology matches their time horizon before trusting any ranking.

What are the Magnificent 7 stocks?

The “Magnificent 7” has become one of the most repeated phrases in modern investing, referring to a group of mega-cap US technology companies that have collectively driven most of the S&P 500’s returns in recent years.

Definition and members

Fidelity Investments, a major US asset manager, references the Magnificent 7 as the group of stocks that have dominated market-cap-weighted indices: typically Apple, Microsoft, NVIDIA, Alphabet (Google), Amazon, Meta (Facebook), and Tesla (Fidelity Investments). These seven companies share a few characteristics: they’re all US-listed, all technology or technology-adjacent, and all have market capitalizations exceeding $500 billion.

Investment rationale

The investment case for the Magnificent 7 rests on several pillars. First, their sheer size means they represent a substantial percentage of any market-cap-weighted index, meaning passive investors automatically hold significant exposure. Second, their cash flows fund massive R&D budgets and share buyback programs, which historically support long-term stock price appreciation. Third, their dominance in cloud computing, AI, advertising, and e-commerce gives them pricing power that smaller competitors struggle to match.

The Interactive Investor data validates this dominance: Microsoft is the #1 most traded US stock by ii customers at 72%, NVIDIA ranks #2 at 51%, and Tesla comes in at #3 at 68% (Interactive Investor). These aren’t just abstract holdings—real money is flowing through them on a daily basis.

The implication: passive investors holding market-cap-weighted index funds have effectively placed a massive bet on these seven companies continuing to outperform. That’s not necessarily bad—it’s just a risk that most people don’t consciously acknowledge.

Which share will double in 3 years?

This is the question that gets retail investors most excited—and the one that reputable sources consistently decline to answer with specifics. The honest reality is that no platform can reliably predict which individual stock will double in three years. What they can do is identify the characteristics that historically precede such moves.

Screeners and criteria

Platforms like Screener.in offer stock screening tools that let users filter for companies with specific financial characteristics—earnings growth rates, P/E ratios, debt levels—that backtesting suggests precede doubling periods (Screener.in). The logic is that companies growing earnings at 30%+ annually for multiple years tend to see their stock prices follow, assuming the market assigns a reasonable multiple to those earnings.

Regencell Bioscience’s +13,300.81% yearly gain illustrates the scale of what’s theoretically possible—and the risks involved (TradingView). A stock that gains that much in a single year is almost certainly a micro-cap with extreme volatility. The same dynamics that created those gains can erase them completely.

Historical examples

A common thought experiment asks: what if you had invested $1,000 in Coca-Cola 30 years ago? The answer illustrates the power of dividends reinvested over decades rather than the dramatic short-term gains most investors actually seek. Coca-Cola’s consistent 3-4% annual dividend yield, combined with steady price appreciation, turns a $1,000 investment into something substantially larger over 30 years—but the doubling happens slowly, year by year, rather than in a dramatic three-year window.

The pattern: chasing doubling stocks means accepting a roughly 50/50 chance of losing half your investment in the same timeframe. The math favors patient dividend investors over lottery-ticket seekers.

How to turn $5,000 into $1 million?

This question gets asked constantly in investing forums, and it’s the wrong framing for most people. The math of turning $5,000 into $1 million requires either extraordinary returns over a long period or a substantial initial capital injection—both scenarios that carry significant risk.

Compound interest role

The Investopedia guide on growing $5,000 to $1 million with compound interest illustrates the mathematics clearly. To reach $1 million from $5,000 in 30 years requires an annual return of approximately 16.7%—achievable historically through equity index funds, but requiring patience and the ability to withstand market drawdowns. To reach the same goal in 10 years requires approximately 39% annual returns, which is in the territory of the most successful active traders—and even they rarely sustain such returns.

The Rule of 72 provides a quick mental shortcut: dividing 72 by your annual return percentage tells you how many years it takes to double your money. At 10% annual returns, your money doubles roughly every 7.2 years. From $5,000, that means reaching $1 million requires roughly seven doublings, or about 50 years. Even a 15% annual return—which puts you in the top tier of professional managers—still takes over 30 years to get there.

Real estate angle

Research consistently shows that approximately 90% of millionaires created their wealth through real estate, not stocks. This doesn’t mean real estate is inherently superior to equities—it means that leverage (the ability to control a large asset with a relatively small down payment), tax advantages (mortgage interest deductions, depreciation), and transaction costs (real estate moves less frequently than stock portfolios) create different wealth-building dynamics.

The more practical framing might be: what annual return do you need, and over what period? For most people, a 7-10% annual return sustained over 20-30 years—achievable through low-cost index funds—will transform $5,000 into something life-changing, even if it doesn’t reach $1 million.

Summary

The “top shares to buy” question generates enormous search volume precisely because there’s no single right answer—and that’s the key insight. UK volume leaders like Wizz Air, Vistry, and HSBC are chasing different catalysts than US yearly gainers like Regencell Bioscience and D-Wave Quantum, which are chasing different goals than Morningstar’s fundamental picks or the Magnificent 7 mega-caps that dominate index weights and broker flow data. For UK investors using platforms like Barclays, Hargreaves Lansdown, or AJ Bell, the challenge isn’t finding data—it’s figuring out which framework matches their own time horizon and risk tolerance. Momentum chasers will naturally gravitate toward volume leaders and Reddit buzz; long-term investors will prefer the fundamental rigor of analyst-driven picks. Both approaches can work; neither works without discipline and realistic expectations about what “turning $5,000 into $1 million” actually requires in practice. Platforms like Finder UK and TradingView give retail investors access to the same data that institutions use—but the interpretation gap remains vast.